JNJ vs TWIN · P/E 17, rev $49.37B vs P/E 11, rev $381.3M
Johnson & Johnson (JNJ) versus Twin Disc Incorporated (TWIN) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Twin Disc Incorporated (TWIN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported TWIN revenue for 2026-06-30 was $381.3M. Net income was $27.1M. Revenue was up 11.9% from 2025-06-30 to 2026-06-30. TWIN currently screens at market cap $300.1M and trailing P/E 11.2.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. TWIN currently screens at market cap $300.1M and trailing P/E 11.2.
Not investment advice. Open the JNJ and TWIN stock pages for the full models.
Not investment advice.